Feedback unseren Kunden
Ihr Warenkorb
€0.00 (0 artikel)
Search:
Perform search
Produktkategorien

Generisches Aspirin dipyridamole - Aggrenox, Persantine

News
Suche nach Anfangsbuchstaben:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Aggrenox
Generisches Aggrenox reduziert das Schlaganfallrisiko bei PatientInnen, die einen Blutpfropfen im Gehirn hatten oder eine transiente, ischämische Attacke (bekannt als TIA oder Mini-Schlaganfall).
€0.86
Persantine
Generisches Persantin ist für PatientInnen, die eine Herzklappe haben und schützt vor Blutgerinnseln; es wird zusammen mit Antikoagulanten (z.B., Warfarin) verschrieben.
€0.54
Soziale Lesezeichen
Choose your language:



Geld zurückGarantie
Sichereinkaufen

Unsere Rechnungsführung ist zertifiziert durch:

Secure shopping certificates

Special Offer!

  • This RSS feed URL is deprecated

    This RSS feed URL is deprecated, please update.

  • Dipyridamole Market Intelligence and Analysis for Period 2016-2024 - Latest Market Reports By Abhishek Budholiya (press release) (blog)

    Latest Market Reports By Abhishek Budholiya (press release) (blog)Dipyridamole Market Intelligence and Analysis for Period 2016-2024Latest Market Reports By Abhishek Budholiya (press release) (blog)One of the adverse effect of using dipyridamole is that it increases the risk of bleeding, so in order to stop the bleeding it is taken in combination with aspirin.

  • Blood system drugs Market Size, Share Analysis by Manufacturers, Regions, Type and Application to 2022 - MilTech

    Blood system drugs Market Size, Share Analysis by Manufacturers, Regions, Type and Application to 2022MilTechBlood system drugs Market by Application: department of hematology, Internal Medicine, department of surgery, Pharmacy, Hospital Blood system drugs Market by Product Type: by Antianemic Agents, Ferrous sulfate, Ferrous succinate, RHUEPO, Iron-dextrin .

  • TARDIS: Triple Antiplatelet Therapy No Benefit in Stroke, TIA - Medscape

    MedscapeTARDIS: Triple Antiplatelet Therapy No Benefit in Stroke, TIAMedscapeHOUSTON, Texas — Triple antiplatelet therapy was not superior to guideline-recommended treatment with aspirin/dipyridamole or clopidogrel alone in preventing recurrent strokes in patients who had sustained a recent ischemic stroke or transient .

  • Post-Stroke Antiplatelet Bleeding Risk Estimated in New Model - MedPage Today

    Post-Stroke Antiplatelet Bleeding Risk Estimated in New ModelMedPage TodayA new scoring method may modestly help predict serious bleeding risk with antiplatelet drugs after an ischemic stroke or transient ischemic attack (TIA), a study found.

    Copyright © www.ohnerezeptfreikauf.com is an affiliate marketing website. All rights reserved.